Should I buy Ulta Beauty (ULTA) stock or is it too late?

Ulta Beauty · Consumer Discretionary · price $579
Logo Ulta BeautySee the full Ulta Beauty (ULTA) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 68% of its targets hit on this sector (485 calls tested). It aims for $710 (+23 %), call made on August 29, 2026, maturing on August 29, 2027 (46 d ago).

The 9 reliable analysts $645+11 %
The 9 other firms $631+9.0 %
How to read it: the 9 reliable firms are not filtered by optimism — 8 aim above the price, 1 below, hence their $645 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Ulta Beauty

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
JP Morgan78 %+24.2 %32$631 +9%
Goldman Sachs87 %+22.8 %15$667 +15%
Oppenheimer75 %+20.4 %40$650 +12%
Canaccord Genuity81 %+18.4 %16$731 +26%
Evercore ISI Group70 %+15.9 %10$635 +10%
Baird69 %+15.6 %26$700 +21%
DA Davidson77 %+15.0 %22$625 +8%
Raymond James65 %+14.4 %23$790 +36%
In short — Should you invest in Ulta Beauty? Is it too late, still worth it? Analysts are fairly positive (78% buy, median target $633, i.e. +9%), and the most reliable on ULTA targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • 78% of analysts rate it a buy (Buy consensus, 18 ratings) — a sign of market conviction.
  • Median price target $633, i.e. +9% from the current price ($579).
  • The most reliable firm on ULTA, Goldman Sachs (87% hit rate, 15 scored calls), targets $667 (call made on August 28, 2026, maturing on August 28, 2027) (+15%) in its most recent call, and $652 (call made on June 3, 2026, maturing on June 3, 2027) (+13%) in the one coming due soonest.
  • 6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 18 ratings, 4 are neutral.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • Volatile stock: sharp swings — including steep drops — are part of its profile.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on ULTA

Median target $633 (+9%) · 18 ratings · Buy consensus

Strong Buy00%
Buy1478%
Hold422%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Ulta Beauty now?

We won't decide for you. The facts: 78% of analysts rate it a buy, median target $633 (+9%), and Goldman Sachs (most reliable on ULTA, 87%) targets $667. Weigh that against valuation (P/E ~21) and volatility. This is not personalized advice.

Is it too late to invest in Ulta Beauty?

Not according to analysts: the median target ($633) is still +9% above the current price ($579) (most reliable on ULTA: Goldman Sachs, 87%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Ulta Beauty still worth investing in?

It depends on the gap between the price ($579) and its estimated value: analysts target $633 on median (+9%), with 78% buys (most reliable on ULTA: Goldman Sachs, 87%). Cross-check with their real reliability on ULTA and the cautions above. Information, not advice.

What's the main risk in buying ULTA?

The consensus is not unanimous: of 18 ratings, 4 are neutral.

→ Go deeper: the full Ulta Beauty profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)